nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.0162	0.0454	CcSEcCtD
Aclidinium—Diabetes mellitus—Simvastatin—atherosclerosis	0.0128	0.036	CcSEcCtD
Aclidinium—Diabetes mellitus—Niacin—atherosclerosis	0.0118	0.0331	CcSEcCtD
Aclidinium—Nasopharyngitis—Ezetimibe—atherosclerosis	0.0104	0.0294	CcSEcCtD
Aclidinium—Sinusitis—Rosuvastatin—atherosclerosis	0.0102	0.0286	CcSEcCtD
Aclidinium—Rhinitis—Rosuvastatin—atherosclerosis	0.00975	0.0274	CcSEcCtD
Aclidinium—Urinary retention—Niacin—atherosclerosis	0.00973	0.0273	CcSEcCtD
Aclidinium—Nasopharyngitis—Pravastatin—atherosclerosis	0.00901	0.0253	CcSEcCtD
Aclidinium—Infestation NOS—Ezetimibe—atherosclerosis	0.009	0.0253	CcSEcCtD
Aclidinium—Infestation—Ezetimibe—atherosclerosis	0.009	0.0253	CcSEcCtD
Aclidinium—Sinusitis—Lovastatin—atherosclerosis	0.00861	0.0242	CcSEcCtD
Aclidinium—Sinusitis—Ezetimibe—atherosclerosis	0.00845	0.0237	CcSEcCtD
Aclidinium—Sinusitis—Simvastatin—atherosclerosis	0.00806	0.0226	CcSEcCtD
Aclidinium—Cough—Rosuvastatin—atherosclerosis	0.00739	0.0208	CcSEcCtD
Aclidinium—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00729	0.0205	CcSEcCtD
Aclidinium—Sinusitis—Pravastatin—atherosclerosis	0.00728	0.0205	CcSEcCtD
Aclidinium—Rhinitis—Niacin—atherosclerosis	0.0071	0.0199	CcSEcCtD
Aclidinium—Rhinitis—Pravastatin—atherosclerosis	0.00699	0.0196	CcSEcCtD
Aclidinium—Infection—Rosuvastatin—atherosclerosis	0.00686	0.0193	CcSEcCtD
Aclidinium—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00678	0.019	CcSEcCtD
Aclidinium—Vision blurred—Lovastatin—atherosclerosis	0.00676	0.019	CcSEcCtD
Aclidinium—Eye disorder—Niacin—atherosclerosis	0.00661	0.0186	CcSEcCtD
Aclidinium—Vision blurred—Simvastatin—atherosclerosis	0.00632	0.0178	CcSEcCtD
Aclidinium—Cough—Ezetimibe—atherosclerosis	0.00614	0.0173	CcSEcCtD
Aclidinium—Dry mouth—Lovastatin—atherosclerosis	0.00597	0.0168	CcSEcCtD
Aclidinium—Dry mouth—Ezetimibe—atherosclerosis	0.00586	0.0165	CcSEcCtD
Aclidinium—Infection—Lovastatin—atherosclerosis	0.00582	0.0163	CcSEcCtD
Aclidinium—Vision blurred—Niacin—atherosclerosis	0.00581	0.0163	CcSEcCtD
Aclidinium—Vision blurred—Pravastatin—atherosclerosis	0.00572	0.0161	CcSEcCtD
Aclidinium—Infection—Ezetimibe—atherosclerosis	0.00571	0.016	CcSEcCtD
Aclidinium—Nervous system disorder—Ezetimibe—atherosclerosis	0.00563	0.0158	CcSEcCtD
Aclidinium—Infection—Simvastatin—atherosclerosis	0.00544	0.0153	CcSEcCtD
Aclidinium—Cough—Niacin—atherosclerosis	0.00538	0.0151	CcSEcCtD
Aclidinium—Cough—Pravastatin—atherosclerosis	0.00529	0.0149	CcSEcCtD
Aclidinium—Dry mouth—Niacin—atherosclerosis	0.00513	0.0144	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00496	0.0139	CcSEcCtD
Aclidinium—Infection—Pravastatin—atherosclerosis	0.00492	0.0138	CcSEcCtD
Aclidinium—Tachycardia—Niacin—atherosclerosis	0.00491	0.0138	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00473	0.0133	CcSEcCtD
Aclidinium—Diarrhoea—Rosuvastatin—atherosclerosis	0.00473	0.0133	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Niacin—atherosclerosis	0.00434	0.0122	CcSEcCtD
Aclidinium—Headache—Rosuvastatin—atherosclerosis	0.00433	0.0122	CcSEcCtD
Aclidinium—Diarrhoea—Lovastatin—atherosclerosis	0.00401	0.0113	CcSEcCtD
Aclidinium—Diarrhoea—Ezetimibe—atherosclerosis	0.00393	0.011	CcSEcCtD
Aclidinium—Diarrhoea—Simvastatin—atherosclerosis	0.00375	0.0105	CcSEcCtD
Aclidinium—Vomiting—Lovastatin—atherosclerosis	0.00372	0.0105	CcSEcCtD
Aclidinium—Headache—Lovastatin—atherosclerosis	0.00367	0.0103	CcSEcCtD
Aclidinium—Vomiting—Ezetimibe—atherosclerosis	0.00365	0.0103	CcSEcCtD
Aclidinium—Headache—Ezetimibe—atherosclerosis	0.0036	0.0101	CcSEcCtD
Aclidinium—Vomiting—Simvastatin—atherosclerosis	0.00348	0.00979	CcSEcCtD
Aclidinium—Diarrhoea—Niacin—atherosclerosis	0.00344	0.00967	CcSEcCtD
Aclidinium—Headache—Simvastatin—atherosclerosis	0.00343	0.00964	CcSEcCtD
Aclidinium—Diarrhoea—Pravastatin—atherosclerosis	0.00339	0.00952	CcSEcCtD
Aclidinium—Vomiting—Niacin—atherosclerosis	0.0032	0.00899	CcSEcCtD
Aclidinium—Headache—Niacin—atherosclerosis	0.00315	0.00885	CcSEcCtD
Aclidinium—Vomiting—Pravastatin—atherosclerosis	0.00315	0.00885	CcSEcCtD
Aclidinium—Headache—Pravastatin—atherosclerosis	0.0031	0.00872	CcSEcCtD
Aclidinium—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000145	0.000225	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000145	0.000225	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000144	0.000224	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000144	0.000224	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000144	0.000224	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—LPL—atherosclerosis	0.000144	0.000223	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000144	0.000223	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000143	0.000222	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000143	0.000222	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000143	0.000222	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000142	0.000221	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000142	0.000221	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SPP1—atherosclerosis	0.000142	0.000221	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCL8—atherosclerosis	0.000142	0.00022	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—MTHFR—atherosclerosis	0.000141	0.00022	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000141	0.000219	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000141	0.000219	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000141	0.000219	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000141	0.000219	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000141	0.000219	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000141	0.000219	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000141	0.000219	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PRKCG—atherosclerosis	0.00014	0.000217	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000139	0.000216	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000139	0.000216	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000139	0.000216	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PPARA—atherosclerosis	0.000139	0.000215	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SPP1—atherosclerosis	0.000136	0.000212	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCL8—atherosclerosis	0.000136	0.000211	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000136	0.000211	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000135	0.00021	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—AGT—atherosclerosis	0.000134	0.000209	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000134	0.000208	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—HMOX1—atherosclerosis	0.000132	0.000205	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PDGFB—atherosclerosis	0.000132	0.000204	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—APOE—atherosclerosis	0.000132	0.000204	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CAV1—atherosclerosis	0.000131	0.000203	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—APOA1—atherosclerosis	0.00013	0.000202	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.00013	0.000201	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000129	0.000201	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AGT—atherosclerosis	0.000129	0.0002	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000128	0.000199	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOB—atherosclerosis	0.000127	0.000196	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	0.000126	0.000196	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—LEP—atherosclerosis	0.000126	0.000196	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APOE—atherosclerosis	0.000126	0.000196	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CAV1—atherosclerosis	0.000125	0.000194	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APOA1—atherosclerosis	0.000125	0.000193	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KNG1—atherosclerosis	0.000124	0.000192	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KNG1—atherosclerosis	0.000124	0.000192	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000123	0.000191	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AGT—atherosclerosis	0.000123	0.000191	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTM1—atherosclerosis	0.000123	0.000191	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	0.000123	0.000191	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KNG1—atherosclerosis	0.000122	0.00019	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	0.000122	0.000189	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000121	0.000188	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—LPL—atherosclerosis	0.000121	0.000188	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—LEP—atherosclerosis	0.000121	0.000187	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APOE—atherosclerosis	0.000121	0.000187	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	0.000121	0.000187	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ESR1—atherosclerosis	0.00012	0.000187	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PLG—atherosclerosis	0.00012	0.000186	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PLG—atherosclerosis	0.00012	0.000186	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CAV1—atherosclerosis	0.00012	0.000186	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	0.000119	0.000185	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APOA1—atherosclerosis	0.000119	0.000185	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PIK3CG—atherosclerosis	0.000119	0.000185	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—F2—atherosclerosis	0.000119	0.000184	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PLG—atherosclerosis	0.000119	0.000184	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GPX1—atherosclerosis	0.000118	0.000183	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ESR1—atherosclerosis	0.000115	0.000179	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CD36—atherosclerosis	0.000115	0.000178	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PPARG—atherosclerosis	0.000115	0.000178	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—F2—atherosclerosis	0.000114	0.000177	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000114	0.000177	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PIK3CG—atherosclerosis	0.000114	0.000177	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	0.000113	0.000176	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—INS—atherosclerosis	0.000113	0.000175	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	0.000112	0.000174	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MMP3—atherosclerosis	0.00011	0.00017	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MMP3—atherosclerosis	0.000109	0.00017	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF2—atherosclerosis	0.000109	0.00017	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF2—atherosclerosis	0.000109	0.000169	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—MAPK3—atherosclerosis	0.000109	0.000169	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	0.000109	0.000169	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MTHFR—atherosclerosis	0.000109	0.000169	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MMP3—atherosclerosis	0.000108	0.000168	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF2—atherosclerosis	0.000108	0.000168	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—INS—atherosclerosis	0.000108	0.000167	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PPARA—atherosclerosis	0.000107	0.000166	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOB—atherosclerosis	0.000106	0.000165	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL2—atherosclerosis	0.000106	0.000164	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOB—atherosclerosis	0.000106	0.000164	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000105	0.000163	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000105	0.000163	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOB—atherosclerosis	0.000105	0.000163	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EDN1—atherosclerosis	0.000104	0.000162	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	0.000104	0.000162	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EDN1—atherosclerosis	0.000104	0.000162	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF1—atherosclerosis	0.000104	0.000162	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000104	0.000161	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL5—atherosclerosis	0.000104	0.000161	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—AGT—atherosclerosis	0.000103	0.00016	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL5—atherosclerosis	0.000103	0.00016	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ALB—atherosclerosis	0.000103	0.00016	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EDN1—atherosclerosis	0.000103	0.00016	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—INS—atherosclerosis	0.000103	0.00016	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL5—atherosclerosis	0.000102	0.000159	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL2—atherosclerosis	0.000101	0.000157	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—LPL—atherosclerosis	0.000101	0.000157	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOE—atherosclerosis	0.000101	0.000157	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—LPL—atherosclerosis	0.000101	0.000157	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CAV1—atherosclerosis	0.0001	0.000156	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOA1—atherosclerosis	0.0001	0.000155	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—LPL—atherosclerosis	0.0001	0.000155	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF1—atherosclerosis	9.97e-05	0.000155	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SERPINE1—atherosclerosis	9.89e-05	0.000153	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—NOS3—atherosclerosis	9.87e-05	0.000153	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	9.86e-05	0.000153	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	9.82e-05	0.000152	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	9.73e-05	0.000151	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SPP1—atherosclerosis	9.6e-05	0.000149	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SPP1—atherosclerosis	9.57e-05	0.000149	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	9.56e-05	0.000148	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	9.53e-05	0.000148	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SPP1—atherosclerosis	9.48e-05	0.000147	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	9.47e-05	0.000147	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NOS3—atherosclerosis	9.44e-05	0.000147	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	9.43e-05	0.000146	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PIK3CG—atherosclerosis	9.14e-05	0.000142	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NOS3—atherosclerosis	9.04e-05	0.00014	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTGS2—atherosclerosis	9.03e-05	0.00014	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	8.88e-05	0.000138	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	8.85e-05	0.000137	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PPARG—atherosclerosis	8.82e-05	0.000137	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	8.77e-05	0.000136	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AGT—atherosclerosis	8.67e-05	0.000135	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—INS—atherosclerosis	8.65e-05	0.000134	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AGT—atherosclerosis	8.64e-05	0.000134	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AGT—atherosclerosis	8.56e-05	0.000133	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOE—atherosclerosis	8.5e-05	0.000132	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—LEP—atherosclerosis	8.5e-05	0.000132	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—LEP—atherosclerosis	8.47e-05	0.000131	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOE—atherosclerosis	8.47e-05	0.000131	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CAV1—atherosclerosis	8.42e-05	0.000131	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOA1—atherosclerosis	8.4e-05	0.00013	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CAV1—atherosclerosis	8.39e-05	0.00013	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—LEP—atherosclerosis	8.39e-05	0.00013	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOE—atherosclerosis	8.39e-05	0.00013	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCL8—atherosclerosis	8.37e-05	0.00013	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOA1—atherosclerosis	8.37e-05	0.00013	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CAV1—atherosclerosis	8.31e-05	0.000129	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOA1—atherosclerosis	8.29e-05	0.000129	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ESR1—atherosclerosis	8.11e-05	0.000126	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—AKT1—atherosclerosis	8.09e-05	0.000126	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ESR1—atherosclerosis	8.09e-05	0.000126	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	8.02e-05	0.000124	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—F2—atherosclerosis	8.01e-05	0.000124	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ESR1—atherosclerosis	8.01e-05	0.000124	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—F2—atherosclerosis	7.99e-05	0.000124	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—atherosclerosis	7.96e-05	0.000124	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ALB—atherosclerosis	7.93e-05	0.000123	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—F2—atherosclerosis	7.91e-05	0.000123	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	7.75e-05	0.00012	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	7.67e-05	0.000119	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	7.64e-05	0.000119	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—atherosclerosis	7.62e-05	0.000118	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—NOS3—atherosclerosis	7.59e-05	0.000118	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MMP9—atherosclerosis	7.57e-05	0.000118	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	7.57e-05	0.000117	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NFKB1—atherosclerosis	7.49e-05	0.000116	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MAPK8—atherosclerosis	7.37e-05	0.000114	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—AKT1—atherosclerosis	7.35e-05	0.000114	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	7.34e-05	0.000114	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	7.32e-05	0.000114	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—INS—atherosclerosis	7.26e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MMP9—atherosclerosis	7.25e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	7.25e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—INS—atherosclerosis	7.24e-05	0.000112	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	7.18e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—INS—atherosclerosis	7.16e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL2—atherosclerosis	7.14e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL2—atherosclerosis	7.12e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	7.05e-05	0.000109	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL2—atherosclerosis	7.05e-05	0.000109	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	7.03e-05	0.000109	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF1—atherosclerosis	7.02e-05	0.000109	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF1—atherosclerosis	7e-05	0.000109	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTGS2—atherosclerosis	6.94e-05	0.000108	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF1—atherosclerosis	6.93e-05	0.000108	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—VEGFA—atherosclerosis	6.8e-05	0.000106	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—STAT3—atherosclerosis	6.73e-05	0.000105	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	6.67e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	6.65e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	6.58e-05	0.000102	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	6.51e-05	0.000101	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—STAT3—atherosclerosis	6.45e-05	0.0001	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	6.43e-05	9.99e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NOS3—atherosclerosis	6.36e-05	9.88e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NOS3—atherosclerosis	6.34e-05	9.85e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NOS3—atherosclerosis	6.28e-05	9.75e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	6.24e-05	9.69e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	6.16e-05	9.56e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	5.98e-05	9.28e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	5.65e-05	8.76e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	5.63e-05	8.74e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	5.57e-05	8.65e-05	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	5.45e-05	8.47e-05	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	5.44e-05	8.44e-05	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	5.38e-05	8.36e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—atherosclerosis	5.37e-05	8.33e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—atherosclerosis	5.35e-05	8.31e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—atherosclerosis	5.3e-05	8.23e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MMP9—atherosclerosis	5.11e-05	7.93e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MMP9—atherosclerosis	5.09e-05	7.9e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	5.05e-05	7.84e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MMP9—atherosclerosis	5.04e-05	7.83e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	5.04e-05	7.82e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	4.99e-05	7.74e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	4.97e-05	7.71e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	4.95e-05	7.69e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	4.95e-05	7.69e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	4.94e-05	7.66e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	4.9e-05	7.61e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	4.89e-05	7.59e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—atherosclerosis	4.7e-05	7.3e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	4.59e-05	7.12e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	4.57e-05	7.1e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—STAT3—atherosclerosis	4.54e-05	7.05e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—AKT1—atherosclerosis	4.54e-05	7.04e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	4.53e-05	7.03e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—STAT3—atherosclerosis	4.53e-05	7.03e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—atherosclerosis	4.5e-05	6.99e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—STAT3—atherosclerosis	4.48e-05	6.96e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AKT1—atherosclerosis	4.34e-05	6.74e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	4.34e-05	6.73e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	4.32e-05	6.71e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	4.28e-05	6.65e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	4.21e-05	6.53e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	4.2e-05	6.51e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AKT1—atherosclerosis	4.16e-05	6.45e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	4.15e-05	6.45e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—AKT1—atherosclerosis	3.49e-05	5.41e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—atherosclerosis	3.17e-05	4.92e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—atherosclerosis	3.16e-05	4.91e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—atherosclerosis	3.13e-05	4.86e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AKT1—atherosclerosis	2.93e-05	4.54e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AKT1—atherosclerosis	2.92e-05	4.53e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AKT1—atherosclerosis	2.89e-05	4.48e-05	CbGpPWpGaD
